In AD patients, certain microRNAs (miRNAs), including miR-15, miR-185-5p, and miR-342-3p, are downregulated in serum exosomes, while their predicted target, amyloid precursor protein (APP), is abnormally elevated in the AD brain. The gene discussed is APP; the disease is Alzheimer disease.